NSE
Apollo Hospitals Enterprise LimitedAPOLLOHOSP
Apollo Hospitals is India's largest private hospital chain.
| Key products | Hospitals, pharmacies (Apollo Pharmacy), diagnostics and digital health (Apollo 24/7). |
|---|---|
| Geography | India. |
| Competitors | Max Healthcare, Fortis, Manipal, Narayana. |
AI-generated overview — verify before relying on it.
Net institutional flow
+₹1,108.9 Cr
Institutional buyers
23 in / 0 out
High-impact filings
1 · tilt Neutral
Next corporate action
Interim Dividend - Rs 10 Per Sh
ex 2026-02-16
| # | Company | Inst. flow ₹Cr | Deals | Hi-impact | Filing mom. | Buzz | News |
|---|---|---|---|---|---|---|---|
| 1 | CIPLA | +₹1,527.1 Cr | 39 | — | — | +19 | 44 |
| 2 | APOLLOHOSPThis | +₹1,108.9 Cr | 49 | 1 | — | — | — |
| 3 | MAXHEALTH | +₹30.3 Cr | 10 | — | — | — | — |
| 4 | FORTIS | +₹0 Cr | 12 | — | — | — | — |
| 5 | DRREDDY | +₹0 Cr | 4 | — | — | +20 | 46 |
| 6 | SUNPHARMA | +₹0 Cr | 6 | — | — | +15 | 45 |
| 7 | TORNTPHARM | +₹0 Cr | 2 | — | — | — | — |
| 8 | LUPIN | +₹0 Cr | 4 | — | — | — | — |
| 9 | ZYDUSLIFE | +₹0 Cr | 1 | 1 | +1 | — | — |
Ranked by net institutional flow (buys − sells, ₹Cr). Filing momentum = bullish − bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.
SWOT
Strengths
- • Largest private hospital chain in India
- • Strong brand presence across the country
- • Diversified revenue streams through hospitals, pharmacies, and diagnostics
- • Established partnerships with insurance companies and government entities
Weaknesses
- • High operational costs due to large infrastructure investments
- • Dependence on a few key markets (e.g., Hyderabad) for revenue growth
- • Competition from public sector hospitals and emerging private players
- • Regulatory challenges in the healthcare sector
Opportunities
- • Growing demand for healthcare services in urban India
- • Expansion into new markets, such as Southeast Asia
- • Development of digital health platforms to increase patient engagement
- • Partnerships with pharmaceutical companies to expand Apollo Pharmacy's product offerings
Threats
- • Rising competition from public sector hospitals and private players like Max Healthcare
- • Increasing regulatory scrutiny and potential changes in government policies
- • Cybersecurity threats to Apollo 24/7's digital health services
- • Pandemic-related disruptions to hospital operations and revenue streams
AI-generated from our data — verify before relying on it.
- 2026-06-16Filing Preetha Reddy has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities andShareholding Disclosure
- 2026-06-15FilingApollo Hospitals Enterprise Limited has informed the Exchange about Scheme of Arrangement - Additional informaM&A
- 2026-02-16ActionInterim Dividend - Rs 10 Per ShDividend
- 2025-11-19BlockSELL · ₹43.6 CrBOFA SECURITIES EUROPE SA
- 2025-11-19BlockBUY · ₹43.6 CrKADENSA MASTER FUND
- 2025-11-10BlockBUY · ₹69 CrBOFA SECURITIES EUROPE SA
- 2025-11-10BlockSELL · ₹69 CrGOLDMAN SACHS BANK EUROPESE-ODI
- 2025-09-17BlockSELL · ₹40.9 CrGOLDMAN SACHS (SINGAPORE) PTE - ODI
- 2025-09-17BlockBUY · ₹40.9 CrGOLDMAN SACHS BANK EUROPE SE - ODI
- 2025-09-15BlockSELL · ₹31.7 CrGOLDMAN SACHS (SINGAPORE) PTE - ODI
- 2025-09-15BlockBUY · ₹31.7 CrGOLDMAN SACHS BANK EUROPE SE - ODI
- 2025-09-09BlockSELL · ₹33.5 CrGOLDMAN SACHS (SINGAPORE) PTE - ODI
- 2025-09-09BlockBUY · ₹33.5 CrGOLDMAN SACHS BANK EUROPE SE - ODI
- 2025-08-22BulkSELL · ₹1,489.3 CrSUNEETHA REDDY
- 2025-08-22BlockBUY · ₹10.2 CrABU DHABI INVESTMENT AUTHORITY
- 2025-08-22BlockBUY · ₹45.5 CrAXIS MUTUAL FUND
- 2025-08-22BlockBUY · ₹10.2 CrBANK OF INDIA MUTUAL FUND
- 2025-08-22BlockBUY · ₹22 CrBNP PARIBAS FINANCIAL MARKETS
- 2025-08-22BlockBUY · ₹10.2 CrCOPTHALL MAURITIUS INVESTMENT LIMITED
- 2025-08-22BlockBUY · ₹1.5 CrDENDANA INVESTMENTS MAURITIUS LIMITED
- 2025-08-22BlockBUY · ₹336.2 CrEMERGING MARKETS EQUITY TRUST
- 2025-08-22BlockBUY · ₹52.8 CrFIDELITY FUNDS.- INDIA FOCUS FUND
- 2025-08-22BlockBUY · ₹4.6 CrFIDELITY INDIA FUND
- 2025-08-22BlockBUY · ₹180.6 CrGHISALLO MASTER FUND LP
- 2025-08-22BlockBUY · ₹10.2 CrGOLDMAN SACHS (SINGAPORE) PTE
- 2025-08-22BlockBUY · ₹5.7 CrINVESCO MUTUAL FUND
- 2025-08-22BlockBUY · ₹1.1 CrINVESCO MUTUAL FUND
- 2025-08-22BlockBUY · ₹4.4 CrINVESCO MUTUAL FUND
- 2025-08-22BlockBUY · ₹5.3 CrINVESCO MUTUAL FUND
- 2025-08-22BlockBUY · ₹25.1 CrKOTAK MAHINDRA LIFE INSURANCE COMPANY LIMITED
- 2025-08-22BlockBUY · ₹17.7 CrKOTAK MAHINDRA LIFE INSURANCE COMPANY LIMITED
- 2025-08-22BlockBUY · ₹1.2 CrKOTAK MAHINDRA LIFE INSURANCE COMPANY LIMITED
- 2025-08-22BlockBUY · ₹0.6 CrKOTAK MAHINDRA LIFE INSURANCE COMPANY LIMITED
- 2025-08-22BlockBUY · ₹0.3 CrKOTAK MAHINDRA LIFE INSURANCE COMPANY LIMITED
- 2025-08-22BlockBUY · ₹0.2 CrKOTAK MAHINDRA LIFE INSURANCE COMPANY LIMITED
- 2025-08-22BlockBUY · ₹0.2 CrKOTAK MAHINDRA LIFE INSURANCE COMPANY LIMITED
- 2025-08-22BlockBUY · ₹0.2 CrKOTAK MAHINDRA LIFE INSURANCE COMPANY LIMITED
- 2025-08-22BlockBUY · ₹63 CrMORGAN STANLEY ASIA SINGAPORE PTE
- 2025-08-22BlockBUY · ₹71.3 CrMORGAN STANLEY ASIA SINGAPORE PTE
- 2025-08-22BlockBUY · ₹3.7 CrMORNINGSTAR FUNDS TRUST - MORNINGSTAR INTERNATIONAL EQUITY FUND
- 2025-08-22BlockBUY · ₹257.5 CrSOCIETE GENERALE
- 2025-08-22BlockSELL · ₹1,489.3 CrSUNEETHA REDDY
- 2025-08-22BlockBUY · ₹0.2 CrT ROWE PRICE FUNDS SICAV GLOBAL ALLOCATION EXTENDED FUND
- 2025-08-22BlockBUY · ₹7.4 CrT ROWE PRICE FUNDS SICAV EMERGING MARKETS EQUITY FUND
- 2025-08-22BlockBUY · ₹0.1 CrT ROWE PRICE FUNDS SICAV GLOBAL ALLOCATION FUND
- 2025-08-22BlockBUY · ₹1.8 CrT ROWE PRICE GLOBAL ALLOCATION FUND
- 2025-08-22BlockBUY · ₹23.5 CrT ROWE PRICE INSTITUTIONAL EMERGING MARKETS EQUITY FUND
- 2025-08-22BlockBUY · ₹36.2 CrT ROWE PRICE RETIREMENT HYBRID TRUST- T ROWE PRICE NON US EQUITIES TRUST
- 2025-08-22BlockBUY · ₹258 CrT. ROWE PRICE EMERGING MARKETS STOCK FUND
- 2025-08-22BlockBUY · ₹0.3 CrT. ROWE PRICE GLOBAL ALLOCATION FUND
- 2025-08-22BlockBUY · ₹10.2 CrTATA MUTUAL FUND
- 2025-08-22BlockBUY · ₹10.2 CrVIRIDIAN ASIA OPPORTUNITIES MASTER FUND
- 2025-08-22NetDay net −₹1,489.3 Cr
- 2025-08-19ActionDividend - Rs 10 Per ShareDividend
- 2025-02-14ActionInterim Dividend - Rs 9 Per ShareDividend
- 2024-08-16ActionAnnual General Meeting/Dividend - Rs 10 Per ShareDividend
Merged from deals, filings, corporate actions and news — newest first. Compact rolls each day up to net flow + counts. Scope with the range above.
Filings that matter
- 2Shareholding DisclosureNeutral
a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Source PDF → - 7
49 deals · 2025-08-22 → 2025-11-19
| Date | Counterparty | Type | Side | Value |
|---|---|---|---|---|
| 2025-11-19 | BOFA SECURITIES EUROPE SA | Prop / churn | SELL | ₹43.6 Cr |
| 2025-11-19 | KADENSA MASTER FUND | Institution | BUY | ₹43.6 Cr |
| 2025-11-10 | BOFA SECURITIES EUROPE SA | Prop / churn | BUY | ₹69 Cr |
| 2025-11-10 | GOLDMAN SACHS BANK EUROPESE-ODI | HNI / other | SELL | ₹69 Cr |
| 2025-09-17 | GOLDMAN SACHS (SINGAPORE) PTE - ODI | HNI / other | SELL | ₹40.9 Cr |
| 2025-09-17 | GOLDMAN SACHS BANK EUROPE SE - ODI | HNI / other | BUY | ₹40.9 Cr |
| 2025-09-15 | GOLDMAN SACHS (SINGAPORE) PTE - ODI | HNI / other | SELL | ₹31.7 Cr |
| 2025-09-15 | GOLDMAN SACHS BANK EUROPE SE - ODI | HNI / other | BUY | ₹31.7 Cr |
| 2025-09-09 | GOLDMAN SACHS (SINGAPORE) PTE - ODI | HNI / other | SELL | ₹33.5 Cr |
| 2025-09-09 | GOLDMAN SACHS BANK EUROPE SE - ODI | HNI / other | BUY | ₹33.5 Cr |
49 deals in the selected window — corporate actions are scoped to the same period. ~2 years of history available.
News & chatter on APOLLOHOSP
RSS News
0No recent news.
Google News RSS — links open the source.
Investdesk
0No articles yet.
Our coverage.
No Reddit chatter.
r/ posts mentioning the company.
Twitter / X
0No posts.
Posts mentioning the company.